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Regulation of Histone Acetyltransferases
p300 and PCAF by the bHLH Protein Twist
and Adenoviral Oncoprotein E1A
of Twist have been considerably delineated in myogen-
esis, it remains to be clarified how Twist can regulate cell
differentiation in such diverse lineages. The profound
effects that Twist exerts on transcription and cellular
differentiation might result from the inhibition of crucial
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1997). p300 and CBP have common domains and func-Italy
tions and are collectively described here as p300/CBP
unless otherwise specified. p300/CBP is ubiquitously
expressed and regulates a broad spectrum of biological
Summary activities such as cell differentiation, cell cycle control,
apoptosis, and tumorigenesis. p300/CBP is recruited to
Histone acetyltransferases (HAT) play a critical role in specific promoters through interactions with sequence-
transcriptional control by relieving repressive effects specific activators and in turn recruits a second coacti-
of chromatin, and yet how HATs themselves are regu- vator such as PCAF (p300/CBP±associated protein)
lated remains largely unknown. Here, it is shown that (Yang et al., 1996). Among these activators are MyoD
Twist directly binds two independent HAT domains (Eckner et al., 1996; Yuan et al., 1996; Puri et al., 1997a;
of acetyltransferases, p300 and p300/CBP±associated Sartorelli et al., 1997), NF-kB (Perkins et al., 1997),
factor (PCAF), and directly regulates their HAT activi- GATA-1 (Boyes et al., 1998), and p53 (Avantaggiati et
ties. The N terminus of Twist is a primary domain inter- al., 1997; Gu and Roeder, 1997; Lill et al., 1997). These
acting with both acetyltransferases, and the same do- molecules are critical for the execution of certain funda-
main is required for inhibition of p300-dependent mental biological functions such as cell differentiation,
transcription by Twist. Adenovirus E1A protein mimics immunological responses, and apoptosis.
the effects of Twist by inhibiting the HAT activities of In eukaryotic cells, DNA is tightly packed in repressive
p300 and PCAF. These findings establish a cogent chromatin that hampers the access of transcriptional
argument for considering the HAT domains as a direct machinery. One mechanism to overcome such repres-
target for acetyltransferase regulation by both a cellu- sion is believed to involve histone acetylation (reviewed
lar transcription factor and a viral oncoprotein. in Grunstein, 1997; Wade and Wolffe, 1997; Struhl, 1998).
The surprising findings that transcriptional coactivators
p300/CBP and PCAF possess histone acetyltransferaseIntroduction
(HAT) activities have begun to shed light on promoter-
targeted derepression mechanisms (Bannister and Kouz-Twist is a basic helix-loop-helix (bHLH) protein ex-
arides, 1996; Ogryzko et al., 1996; Yang et al., 1996). Inpressed specifically in mesodermal and cranial neural
contrast to the accumulating data on functions of thecrest cells during embryogenesis (Thisse et al., 1988;
coactivators, however, little is known about the cellularWolf et al., 1991; Fuchtbauer, 1995; Stoetzel et al., 1995)
regulation of p300/CBP itself. A lone insight is that viralwhose activity has been implicated in the inhibition of
oncoproteins E1A and SV40 T antigen exert trans-differentiation of multiple cell lineages, including muscle
forming activities, at least in part by perturbing p300/(Hebrok et al., 1994; Spicer et al., 1996; Hamamori et
CBP functions (Yang et al., 1996; Puri et al., 1997b;al., 1997), bone (Murray et al., 1992), and neuronal cells
reviewed in Shikama et al., 1997). Here, we demonstrate(Lee et al., 1995). Although the inhibitory mechanisms
that Twist interacts with the HAT domains and inhibits
acetyltransferase activities of p300 and PCAF. In addi-
tion, we show that viral oncoprotein E1A mimics the‖ To whom correspondence should be addressed (e-mail: kedes@
hsc.usc.edu). effects of Twist in inhibiting the HAT activities. These
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findings provide evidence for a novel and unifying mech-
anism to explain the effects of viral and cellular proteins
on fundamental aspects of cell function through the
regulation of acetyltransferases.
Results
Twist Interacts with p300 and PCAF In Vitro
and In Vivo
On the basis of functional similarities between E1A and
Twist, we first tested whether Twist interacted with p300
in vitro and in vivo. Total cell extracts from C2C12 myo-
tubes were incubated with equal amounts of either GST-
Twist, a control GST-E1A, or GST alone. GST-Twist and
GST-E1A, but not GST alone, interacted with cellular
p300 (Figure 1A). To further determine whether this
interaction occurs in vivo, we took a cotransfection
approach, given a lack of appropriate Twist protein-
expressing cell lines. COS7 cells were transiently trans-
fected either with a vector for myc-tagged Twist (myc-
Twist) alone (Figure 1B, lane 1) or a combination of the
two vectors for myc-Twist and Flag-tagged p300 (lanes
2 and 3). Extracts from the transfected cells were first
immunoprecipitated with either anti-Flag M2 antibody
(lanes 1 and 2) or an unrelated HA antibody (lane 3).
The associated proteins were subjected to Western blot
analysis with anti-myc antibody (9E10.2). An intense
band corresponding to myc-Twist was readily detected
only when Flag-p300 was expressed and immunopre-
cipitated by the Flag antibody (lane 2), indicating that
Twist specifically interacted with p300 in vivo. Since
PCAF colocalizes with p300 to form a multiprotein com-
plex (Yang et al., 1996; Puri et al., 1997b), we asked
whether PCAF might also be a target of Twist. Using
essentially the same strategy, we found that GST-Twist
specifically interacted with cellular PCAF, as detected
by Western blot analysis using an anti-PCAF antibody
(Figure 1C). The interaction was further confirmed in
vivo by transiently expressing Flag-PCAF and myc-
Twist. Myc-Twist was detected only when PCAF was
coexpressed and immunoprecipitated (Figure 1D, lane
1). These findings demonstrate that Twist can interact
either directly or indirectly with the two histone acetyl-
transferases p300 and PCAF both in vitro and in vivo.
Twist Interacts Directly with the Two Independent
HAT Domains through Its N Terminus
Figure 1. Twist Interacts with Endogenous and Recombinant p300A number of transcriptional activators, coactivators, and
as well as PCAF In Vitro and In Vivoviral proteins have been shown to have functional inter-
(A) Total cell extracts from C2C12 muscle cells were incubated withactions with distinct domains of p300/CBP and PCAF
GST-Twist bound to glutathione-agarose beads. Bound proteins(summarized in Figure 2). As a first step toward under-
were analyzed by Western blot using an anti-p300 antibody. (*) Anstanding the functional significance of the interactions
unidentified protein of z80 kDa is frequently observed (Lill et al.,
between Twist and p300 as well as PCAF, we wished 1997; Dallas et al., 1998).
to delineate the domains engaged in their association. (B) U2OS cells were cotransfected with vectors expressing Flag-
tagged p300 and myc-epitope-tagged Twist. ImmunoprecipitationGST pull-down studies were performed using GST-Twist
was performed on cell extracts with either the Flag- or control HA-and a series of in vitro±translated [35S]p300 proteins (Fig-
antibody, followed by Western blot analysis to detect myc-Twist.ure 3). Twist strongly bound the C-terminal fragment
(C) Interaction between cellular PCAF and immobilized GST-Twist(amino acids 1257±2414) of p300 spanning the HAT do-
was detected by Western blot analysis with anti-PCAF antibody.
main as well as the CH3 domain. Further deletion re- (D) In vivo interaction between transfected Twist and PCAF was
vealed that this interaction requires the CH3 domain detected by Western blot analysis using a myc antibody.
(compare 1572±2414 and 1869±2414), which is known
to interact with other proteins. An isolated CH3 fragment
Twist Inhibits Histone Acetyltransferases
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Figure 2. Schematic Representations of p300,
PCAF, and Twist and Their Interaction Do-
mains
Proteins known to interact with p300, PCAF,
and Twist are indicated above each inter-
acting domain. The bold lines indicate the
interacting domains determined in the pres-
ent study. CH3, cysteine-histidine-rich region
3; Bromo, bromodomain; HAT, histone ace-
tyltransferase.
alone also supported the interaction with GST-Twist (not common motifs present in these HAT domains (Neuwald
and Landsman, 1997; Martinez-Balbas et al., 1998). Theshown). Of particular interest, Twist retained an interac-
tion with a HAT domain even in the absence of the CH3 functional significance of Twist's interaction with the
PCAF bromodomain remains to be studied. To deter-domain (1257±1572) (Figure 3). Twist also bound the
N terminus of p300 (1±566 and 1±744), although these mine which domains of Twist interact with p300 and
PCAF, equal amounts of various Twist protein fragmentsinteractions were 5- to 10-fold weaker than those with
the CH3 and HAT domains. fused to GST were incubated with in vitro±translated
p300 and PCAF (Figure 5). We found that the N terminusIncubation of GST-Twist with affinity-purified PCAF
showed strong binding (.20% of the input) (Figure 4, of Twist is a primary interacting site for both p300 and
PCAF, while a bHLH domain may also contribute to bothtop). Intriguingly, experiments using a series of PCAF
internal deletion mutants revealed that this interaction interactions, albeit to a much lesser degree (Figure 5).
This provides us with a new insight as to roles of the Nrequired the presence of the intact HAT domain and
bromodomain (Figure 4). Thus, Twist interacts indepen- terminus of Twist, since we have previously found that
this domain is necessary for efficient inhibition of MyoDdently with the HAT domains of two different proteins,
p300 and PCAF, suggesting that Twist may recognize transcription by Twist, and yet in contrast to the other
Figure 3. Twist Interacts with the HAT and CH3 Domains of p300
In vitro±translated [35S]p300 fragments were incubated with GST-Twist immobilized on glutathione-agarose beads. The bound proteins were
analyzed by autoradiography after SDS-PAGE (top). Summary of p300 domain mapping for the interaction with Twist (bottom). The bound
p300 fragments were quantified by a phosphoimager using the fragment 1257±1572 as a standard (100%). 111, 81%±100% of interaction;
11, 61%±80%; 1, 41%±60%; 6, 21%±40%; 2, 0%±20%.
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other preparations of Twist, including GST-Twist and
histidine-tagged Twist, but not by GST-MyoD or histi-
dine-MyoD (not shown). The N terminus of Twist, which
provides a primary binding site for both p300 and PCAF
(Figure 5), was required for the inhibition of acetylation,
since deletion of the N terminus (DN Twist) drastically
diminished the inhibitory effects (Figure 6A). In addition
to histones, p300 and PCAF are known to acetylate and
modify the functional properties of several nonhistone
substrates (Gu and Roeder, 1997; Imhof et al., 1997;
Boyes et al., 1998; Waltzer and Bienz, 1998). We noted
that p300 auto- (or cross-) acetylated itself (Figure 6A,
middle left). Although the functional significance of this
autoacetylation remains to be studied, it was inhibited
by Twist in a manner similar to the acetylation of his-
tones, and thus autoacetylation provides an excellent
measure to monitor regulation of acetyltransferase ac-
tivities by Twist.
Because of a number of common features shared by
Figure 4. Twist Interacts with the C-Terminal HAT- and Bromodo- E1A and Twist as well as the association of E1A with
mains of PCAF p300, we hypothesized that E1A might also mimic the
The affinity-purified Flag-PCAF deletion mutant proteins (1 pmol) inhibitory effects of Twist on histone acetyltransferases.
were incubated with immobilized GST-Twist followed by Western
Indeed, E1A efficiently inhibited the HAT activities ofblot analysis with anti-Flag antibody.
both p300 and PCAF (Figure 6B). However, the E1A
inhibition was more substrate specific. In fact, whereas
Twist caused a general reduction in histone acetylation,domains of Twist, a precise role of the N terminus has
E1A selectively inhibited acetylation of H3 and H4. Unlikebeen undefined (see Figure 2).
p300, PCAF is known to preferentially acetylate H3 and
H4 among the four core histones (Yang et al., 1996), andTwist and E1A Inhibit HAT Activities of p300
E1A also inhibited the acetylation of both H3 and H4 byand PCAF In Vitro
PCAF. These findings illustrate how E1A mimics Twist byThe finding that Twist directly binds the HAT domains
inhibiting the HAT activities of p300 and PCAF, althoughof both p300 and PCAF (Figures 3 and 4) prompted us
E1A appears to have additional mechanisms enablingto test the hypothesis that Twist might affect their HAT
E1A to distinguish different substrates.activities through these direct interactions with the HAT
domains. Affinity-purified p300 and PCAF were able to
acetylate histones in the presence of [14C]acetyl-CoA Twist and E1A Inhibit HAT Activities In Vivo
To study whether Twist and E1A inhibit the acetyltrans-(Figure 6A). However, such acetylation was completely
abrogated upon an addition of Twist. The inhibition was ferases in cells, we transiently transfected cells with
expression vectors for Flag-p300 and PCAF togetherspecific to Twist, since it was also observed using a few
Figure 5. The N Terminus of Twist Interacts
with Both p300 and PCAF
Twist fragments fused to GST were incubated
with in vitro±translated [35S]p300 or [35S]PCAF.
The bound proteins were analyzed by autora-
diography after SDS-PAGE. The bound p300
or PCAF was quantified using a phospho-
imager and the results shown using GST-
Twist1-206 as a standard (100%) (bottom).
111, 81%±100% of interaction; 11, 61%±
80%; 1, 41%±60%; 6, 21%±40%; 2, 0%±
20%. N/D, not determined.
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with vectors for Twist or E1A and monitored the acetyla-
tion of p300. When either p300 or PCAF alone was ex-
pressed, only a slight p300 autoacetylation was ob-
served (not shown). However, when p300 and PCAF
were coexpressed, we observed a robust p300 acetyla-
tion that allowed us to study possible inhibitory effects
of Twist and E1A on acetyltransferase activities (Figure
6C). In line with the in vitro HAT inhibition (Figures 6A
and 6B), this in vivo acetylation was completely inhibited
in the presence of either Twist or E1A (Figure 6C). Each
immunoprecipitate contained an equal amount of Flag-
p300 protein as determined by Western blot analysis
using an aliquot of the precipitates (Figure 6C, bottom).
These results, together with in vitro inhibition of HATs
by Twist and E1A supported by the direct interactions,
demonstrate that both Twist and E1A target the acetyl-
transferase activities in the cells.
Twist Requires the Same N-Terminal Domain
for Inhibition of Both HAT Activities
and p300-Dependent Transcription
To further analyze functional implications of the interac-
tions between Twist and the HAT coactivators, we stud-
ied the effects of Twist on different types of transcrip-
tional activators. We used plasmids encoding the Gal4
DNA-binding domain fused to various activators (Figure
7A). Some of these activators were selected because
they are inhibited by E1A through mechanisms thought
to involve p300. Both Twist and E1A inhibited all tested
p300-dependent acidic activators (MyoD, VP16, p53)
but not the glutamine-rich activation domain of Sp1,
suggesting that Twist specifically targets p300-depen-
dent transcription. The MyoD N-terminal activation do-
main (amino acids 1±54) contains the FYD motif that is
conserved among the MyoD family and is required for
both physical interaction with and coactivation by p300
(Sartorelli et al., 1997). Although Twist did not directly
bind this activation domain of MyoD (Hamamori et al.,
1997), Twist efficiently inhibited transcription from Gal-
MyoD1±54, and this inhibition was completely rescued
by p300 and PCAF (Figure 7B). Notably, this inhibition
required the N terminus of Twist, a domain required for
the physical interaction with p300 and PCAF as well as
for the inhibition of their HAT activities (Figure 7C). In
these experiments, the truncated Twist proteins were
equally well expressed in the transfected cells (Hama-Figure 6. The HAT Activities of Both p300 and PCAF Are Inhibited
mori et al., 1997). Taken together, these findings supportby Twist and E1A In Vitro and In Vivo
the view that Twist suppresses the coactivator functions(A) In vitro inhibition of HATs by Twist on two different substrates.
Purified p300 or PCAF was preincubated with Twist before adding of p300 and PCAF through physical interactions medi-
purified histones and [14C]acetyl-CoA. Acetylated histones were de- ated by the N terminus of Twist. Since the same N termi-
tected by autoradiography after SDS-PAGE. p300 autoacetylation nus of Twist is also required for the HAT inhibition, and
was similarly inhibited by Twist (middle left). The relative amounts
transiently transfected plasmids are rapidly chroma-of acetylated histones were quantitated using a phosphoimager and
tinized (Reeves et al., 1985; Pullner et al., 1996; Stanfield-expressed as percentage HAT inhibition (bottom graph).
Oakley and Griffith, 1996), the inhibition of HAT activities(B) E1A abolishes the HAT activities of p300 and PCAF. Assays
similar to those described in (A) were performed using purified E1A. may be one of the mechanisms for the observed inhibi-
The data shown is a composite of two different exposure periods tion of p300-dependent transcription by Twist.
(3 days for p300 and 7 days for PCAF) from the same film. Acetylated
histone isoforms (H3, H2A/H2B, and H4) were individually quanti-
tated by a phosphoimager (bottom graph).
(C) Both Twist and E1A abolish the HAT activities in vivo. C2C12
radiography (top). Ten percent of each immunoprecipitate was sub-cells were transfected with the indicated vectors and pulsed with
[3H]sodium acetate. Flag-p300 was immunoprecipitated with the jected to Western blot analysis to ascertain whether an equal
amount of p300 was analyzed (bottom).Flag-antibody, and [3H]acetylated Flag-p300 was detected by auto-
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Discussion
Histone Acetyltransferase Domains as a Direct
Target of Twist
Twist employs several specific mechanisms to regulate
cellular differentiation. For instance, Twist inhibits mus-
cle differentiation by E protein sequestration and by
interactions with MyoD and MEF2 proteins (Spicer et
al., 1996; Hamamori et al., 1997). However, Twist also
inhibits transcription from the specific activation do-
mains independent of the above mechanisms (Figure
7A), and therefore a new mechanism must be involved.
We provide here a unifying explanation of the more gen-
eral and profound effects exerted by Twist on multiple
and critical cellular functions such as cell differentiation
and proliferation. Here, we demonstrate that the cellular
transcription factor Twist directly binds p300 and PCAF
acetyltransferases using its N terminus, whose function
has been so far undetermined. The binding of Twist to
the coactivators is directed to the HAT domains of both
p300 and PCAF and results in the inhibition of their
acetyltransferase activities. These HATs belong to a
large N-acetyltransferase superfamily whose members
share several conserved motifs (Neuwald and Lands-
man, 1997; Martinez-Balbas et al., 1998). An amino acid
sequence alignment of N-acetyltransferases from nu-
merous species has revealed four conserved motifs
(A-D) within the acetyltransferase domain. Motifs A and
B have been thought to be the binding site of acetyl-
CoA by several mutagenesis experiments (Tercero et
al., 1992; Coleman et al., 1996; Lu et al., 1996). In addition
to motifs A and B, p300/CBP and PCAF have another
motif, E, that appears to be more unique to them (Marti-
nez-Balbas et al., 1998). The finding that Twist binds to
the two HAT domains that belong to this superfamily
and modifies their enzymatic activities suggests a new
general scheme for acetyltransferase regulation by the
cellular transcription factor Twist. One attractive model
for the HAT inhibition by Twist is to prevent acetyl-CoA
binding to motifs A and B. Twist might regulate HAT
activities of not only p300 and PCAF but also other
members of the N-acetyltransferase family by inter-
acting with common motifs such as A and B. Alterna-
tively, Twist might specifically regulate p300 and PCAF
by binding to the more unique E motif.
The N terminus of Twist is the primary binding site for
both p300 and PCAF (Figure 5), and yet DN Twist still
shows weak HAT inhibition in vitro (Figure 6A). One pos-
sible explanation for this is that the N terminus of Twist
may not be the only domain responsible for the HAT
inhibition, and DN Twist (a combination of the bHLH
domain and C terminus) might also carry an inhibitory
domain. In line with this interpretation, DN Twist that
contains an intact bHLH domain retains weak but signifi-
Figure 7. Twist Specifically Inhibits p300- and PCAF-Dependent cant binding activities to both p300 and PCAF (Figure
Transcription, and the Inhibition Requires the N Terminus of Twist
(A) Both Twist and E1A inhibit activities of several p300-dependent
transcription factors but not that of the glutamine-rich activator
Sp1. U2OS cells were transfected with G4M2-luciferase (1 mg) and (C) The N terminus of Twist is required for transcriptional inhibition.
expression vectors encoding a Gal4 DNA-binding domain fused to Cells were transfected with Gal-MyoD1±54 and Twist deletion mutant
the indicated activators (1 mg) and either Twist or E1A. vectors (top). A summary of transcriptional inhibition by Twist on
(B) Rescue by p300 and PCAF of the Twist inhibition of transcription. Gal-MyoD1±54 is shown at the bottom. Wild-type (wt) Twist is set as
Cells were cotransfected with the Gal-MyoD1±54, Twist, p300, or a standard at 100% inhibition. 111, 81%±100% of inhibition; 11,
PCAF expression vectors as indicated. 61%±80%; 1, 41%±60%; 6, 21%±40%; 2, 0%±20%.
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5). In the in vitro studies where relatively high concentra- Analogy between Twist and E1A
Throughout this paper, we have provided an intriguingtions of Twist can be used, such weak binding might
be sufficient to observe marginal HAT inhibition (Figure analogy between the functions of Twist and E1A: both
Twist and E1A inhibit MyoD transcription and myogen-6A). In contrast, the high affinity binding provided by
the N terminus may be critical for efficient inhibition in esis (Webster et al., 1988; Braun et al., 1992; Caruso et
al., 1993; Hebrok et al., 1994; Spicer et al., 1996; Hama-vivo (Figure 7C) where the concentration of Twist is
unlikely to reach the level achieved in the in vitro studies. mori et al., 1997), bind to p300 and PCAF (Reid et al.,
1998; this paper), inhibit the HAT activities of these co-It will be necessary to determine specific interactions
between the motifs of HAT domains and Twist domains activators (this paper), and can antagonize p53-induced
cell cycle arrest and apoptosis (Lill et al., 1997; Maestroin order to better understand the detailed mechanisms
of how Twist modulates HAT activities. A similar regula- et al., submitted). Furthermore, we have more recently
noted that Twist expression is upregulated in humantory mechanism might also be shared by other Twist-
related bHLH proteins such as paraxis and dermo-1 that rhabdomyosarcoma tissues, making it likely that Twist
is an oncoprotein (Maestro et al., submitted). The avail-have extensive sequence similarity with Twist (Querter-
mous et al., 1994; Burgess et al., 1995; Cserjesi et al., ability of such Twist-expressing cells would allow us
to analyze physical interactions between endogenous1995; Li et al., 1995).
The molecular mechanism by which E1A regulates Twist and acetyltransferases as well as a role of such
interactions in tumorigenesis. Given the common fea-HAT activity remains to be elucidated. E1A, by binding
to the CH3 domain, might modify activities of the adja- tures between E1A and Twist, many of the reported
biological activities of E1A might in fact reflect some ofcent HAT domain through conformational changes. Al-
ternatively, E1A might interact directly with the HAT do- the physiological functions exerted by a cellular tran-
scriptional factor, Twist.mains of p300 and PCAF as does Twist.
E1A has recently been shown to activate the HAT
activity of CBP in G1/S phase transition (Ait-Si-Ali et
A Dual Mechanism for Coactivator Regulation
al., 1998). This is in contrast to our observation of the
E1A has been shown to bind the CH3 domain of p300/
inhibition of HAT activities of p300 by E1A and to other
CBP and to displace PCAF from this domain (Yang et al.,
reports describing repression of p300 by E1A (Arany et
1996). Previously, we and others interpreted the effect of
al., 1995; Flint and Shenk, 1997; reviewed in Shikama et
E1A as a simple competition between E1A and PCAF
al., 1997). Although several differences in experimental
for the CH3 domain. Our present study adds a further
conditions are readily noted, the exact reasons for the
level of complexity by demonstrating that E1A and Twist
apparent discrepancy remain to be clarified. One possi-
may exert their inhibition not only by physically dis-
ble explanation is that E1A differentially regulates p300
rupting the p300-PCAF complex formation but also
and CBP. In fact, several contrasting properties of p300
through suppression of their enzymatic activities. The
and CBP have been recently described, including their
interaction of Twist at the CH3 domain raises the in-
effects on F9 cell differentiation and expression of cell
triguing possibility that Twist might also prevent PCAF
cycle inhibitors p21 and p27 (Kawasaki et al., 1998).
association with p300/CBP by competing with PCAF for
Furthermore, p300 and CBP may be differentially phos-
the common CH3 domain. These two mechanisms may
phorylated (Ait-Si-Ali et al., 1998; P. L. Puri et al., unpub-
not necessarily work simultaneously, and cells would
lished results), which may be directly relevant to the
have exquisite control mechanisms that determine how
observed discrepancy, since phosphorylation of CBP
these two mechanisms of p300 and PCAF regulation
has been proposed to increase its HAT activity and E1A
may be differentially utilized in a given situation. We
mimics the effect of phosphorylation of CBP to enhance
have previously demonstrated that individual histone
its HAT activity (Ait-Si-Ali et al., 1998). Thus, the HAT
acetyltransferases have distinct roles (Puri et al., 1997b).
domains of p300 and CBP might be differentially regu-
For instance, myogenic transcription and differentiation
lated by E1A.
are dependent on the HAT activity of PCAF but not on
that of p300/CBP. Similar observations are made in
other systems, indicating that the transcriptional activi-Genetic Interaction between Twist and p300
ties of the HAT domains of p300 and PCAF are highlyMouse knockout models for Twist and p300 genes show
promoter dependent (Korzus et al., 1998). The dual inhib-both similar and dissimilar phenotypes (Chen and Beh-
itory mechanisms involving the HAT inhibition as well asringer, 1995; Yao et al., 1998). Although mice homozy-
the competitive displacement of cofactors would allowgous for either p300 or Twist gene disruption show open
E1A and possibly Twist to regulate a broad range ofneural tube defects, heterozygous mice show different
transcriptional activators that are differentially depen-phenotypes: p3001/2 mice show exencephaly, while
dent on p300 and PCAF and their HAT activities.twist1/2 mice have craniosynostosis. Although our bio-
chemical data do not provide immediate explanations
for these phenotypes, these phenotypes indicate a ge- Experimental Procedures
netic link between Twist and p300. The expression of
Plasmids and Transient TransfectionsTwist and p300 in multiple overlapping regions of mouse
Mammalian expression vectors for Twist, p300, PCAF, E1A12S, andembryos (Thisse et al., 1988; Wolf et al., 1991; Chen and
various Gal fusions were described previously (Hamamori et al.,
Behringer, 1995; Fuchtbauer, 1995; Stoetzel et al., 1995; 1997; Puri et al., 1997b; Sartorelli et al., 1997). Cells were transfected
Yao et al., 1998) is also consistent with the observed by the BES-buffered saline (BBS) method as described before (Ha-
mamori et al., 1997). G4M2-luciferase carries Gal4 DNA-binding sitesmolecular interaction between them.
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and an adenoviral major late TATA box (kindly provided by T. Kouzar- by cycle-dependent kinases and oncoprotein E1A. Nature 396,
184±186.ides, Wellcome/CRC Institute).
Arany, Z., Newsome, D., Oldread, E., Livingston, D., and Eckner, R.
In Vitro Interaction Studies (1995). A family of transcriptional adaptor proteins targeted by the
GST-Twist and GST-E1A12S were prepared from E. coli cells as E1A oncoprotein. Nature 374, 81±84.
described (Hamamori et al., 1997). In vitro [35S]methionine-labeled Avantaggiati, M., Ogryzko, V., Gardner, K., Giordano, A., Levine, A.,
proteins were prepared using the TNT coupled transcription-transla- and Kelly, K. (1997). Recruitment of p300/CBP in p53-dependent
tion system (Promega). Labeled proteins were incubated with equal signal pathways. Cell 89, 1175±1184.
amounts of either GST fusion protein for 1 hr at 48C. Bound proteins
Bannister, A., and Kouzarides, T. (1996). The CBP co-activator is awere analyzed by autoradiography after SDS-PAGE.
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